SCHEMBL7052448

SCHEMBL7052448

COC(=O)C1=C(OS(=O)(=O)C(F)(F)F)CCN(Cc2cncn2Cc2ccc(C#N)cc2)C1

nearest known ligand 0.49

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 3/20 0.49
CYP11B2 P19099 3/20 0.49
FNTA P49354 17/20 0.48
FNTB P49356 17/20 0.48
PGGT1B P53609 15/20 0.48
NRAS P01111 1/20 0.44
HRAS P01112 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7047892 0.83 CYP11B1 (0.58) CYP11B1CYP11B2FNTAFNTBPGGT1B
SCHEMBL2794854 0.77 CHRM2 (0.46)
SCHEMBL7050806 0.76 FNTA (0.61) CYP11B1CYP11B2FNTAFNTBPGGT1B
SCHEMBL8487144 0.71 PRKAA2 (0.53) CYP11B1CYP11B2FNTAFNTBPGGT1B
SCHEMBL7743501 0.70 FNTA (0.54) CYP11B1CYP11B2FNTAFNTBPGGT1B
SCHEMBL7665146 0.70 FNTA (0.73) CYP11B1CYP11B2FNTAFNTBPGGT1B
SCHEMBL7743768 0.69 FNTA (0.66) CYP11B1CYP11B2FNTAFNTBPGGT1B
SCHEMBL28275795 0.69 FNTA (0.67) CYP11B1CYP11B2FNTAFNTBPGGT1B
SCHEMBL7047853 0.69 FNTA (0.64) FNTAFNTBPGGT1BNRASHRAS
SCHEMBL1901800 0.69 MEN1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030216441-A1 Farnesyltransferase inhibitors WEINSTOCK, STEVEN F. 2003-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030216441-A1 Farnesyltransferase inhibitors FNTA, FNTB, LCAT CYP11B1 151/4885CYP11B2 221/4885FNTA 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.